Clinical Trial Update: A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating how metabolism responds to weight loss when combining cagrilintide with semaglutide compared with diet in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Cagrilintide (cagrilintide)
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: RECRUITING